NM_002769.5:c.116T>C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_002769.5(PRSS1):c.116T>C(p.Val39Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_002769.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary chronic pancreatitisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 37
GnomAD4 exome Cov.: 84
GnomAD4 genome Cov.: 37
ClinVar
Submissions by phenotype
Hereditary pancreatitis Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces valine with alanine at codon 39 of the PRSS1 protein (p.Val39Ala). The valine residue is highly conserved and there is a small physicochemical difference between valine and alanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with chronic pancreatitis (PMID: 16227369). It has also been observed to segregate with disease in related individuals. Experimental studies have shown that this variant affects PRSS1 protein function (PMID: 22539344). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at